Matches in SemOpenAlex for { <https://semopenalex.org/work/W4238208545> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W4238208545 endingPage "26" @default.
- W4238208545 startingPage "22" @default.
- W4238208545 abstract "The effect of the anti-hypertensive drug eprosartan on metabolic parameters is currently not extensively documented. We evaluated the effect of eprosartan on parameters involved in atherogenesis, oxidative stress and clotting activity. This open-label unblinded intervention study included 40 adult patients with essential hypertension taking eprosartan. Eprosartan significantly reduced by 8% (p<0.001) the systolic and by 13% (p<.001) the diastolic blood pressure, and in-creased by 24% the time needed to produce oxidative by-products (p=0.001), a marker of oxidative stress. In contrast, ep-rosartan did not alter 8-isoprostane (8-epiPGF2a) levels, another marker of oxidative stress. Additionally, eprosartan re-duced by 14% aspartate aminotransferase and by 21% then alanine aminotransferase activity, while it had a neutral effect on the lipid profile and apolipoprotein levels and did not influence glucose homeostasis, creatinine and uric acid levels. Eprosartan did not affect the clotting/fibrinolytic status (estimated by plasminogen activator inhibitor 1, tissue plasmino-gen activator and a2 antiplasmin levels), or the enzymatic activity of the lipoprotein associated phospholipase A2 (Lp-PLA2) and paraoxonase 1 (PON1). In conclusion, eprosartan should be mainly considered as an anti-hypertensive agent with neutral effects on most of the metabolic parameters in hypertensive patients." @default.
- W4238208545 created "2022-05-12" @default.
- W4238208545 creator A5021807110 @default.
- W4238208545 creator A5034798180 @default.
- W4238208545 creator A5038506373 @default.
- W4238208545 creator A5040968216 @default.
- W4238208545 creator A5049632923 @default.
- W4238208545 creator A5054315768 @default.
- W4238208545 creator A5056379080 @default.
- W4238208545 date "2007-11-30" @default.
- W4238208545 modified "2023-09-27" @default.
- W4238208545 title " Effects of Eprosartan on Serum Metabolic Parameters in Patients with Essential Hypertension" @default.
- W4238208545 doi "https://doi.org/10.2174/187419240701012204" @default.
- W4238208545 hasPublicationYear "2007" @default.
- W4238208545 type Work @default.
- W4238208545 citedByCount "0" @default.
- W4238208545 crossrefType "journal-article" @default.
- W4238208545 hasAuthorship W4238208545A5021807110 @default.
- W4238208545 hasAuthorship W4238208545A5034798180 @default.
- W4238208545 hasAuthorship W4238208545A5038506373 @default.
- W4238208545 hasAuthorship W4238208545A5040968216 @default.
- W4238208545 hasAuthorship W4238208545A5049632923 @default.
- W4238208545 hasAuthorship W4238208545A5054315768 @default.
- W4238208545 hasAuthorship W4238208545A5056379080 @default.
- W4238208545 hasBestOaLocation W42382085451 @default.
- W4238208545 hasConcept C104317684 @default.
- W4238208545 hasConcept C126322002 @default.
- W4238208545 hasConcept C134018914 @default.
- W4238208545 hasConcept C135763542 @default.
- W4238208545 hasConcept C185592680 @default.
- W4238208545 hasConcept C2776151105 @default.
- W4238208545 hasConcept C2776509667 @default.
- W4238208545 hasConcept C2776919658 @default.
- W4238208545 hasConcept C2778163477 @default.
- W4238208545 hasConcept C2778913445 @default.
- W4238208545 hasConcept C2779881121 @default.
- W4238208545 hasConcept C2780072125 @default.
- W4238208545 hasConcept C2780306776 @default.
- W4238208545 hasConcept C37501387 @default.
- W4238208545 hasConcept C55493867 @default.
- W4238208545 hasConcept C71924100 @default.
- W4238208545 hasConcept C84393581 @default.
- W4238208545 hasConceptScore W4238208545C104317684 @default.
- W4238208545 hasConceptScore W4238208545C126322002 @default.
- W4238208545 hasConceptScore W4238208545C134018914 @default.
- W4238208545 hasConceptScore W4238208545C135763542 @default.
- W4238208545 hasConceptScore W4238208545C185592680 @default.
- W4238208545 hasConceptScore W4238208545C2776151105 @default.
- W4238208545 hasConceptScore W4238208545C2776509667 @default.
- W4238208545 hasConceptScore W4238208545C2776919658 @default.
- W4238208545 hasConceptScore W4238208545C2778163477 @default.
- W4238208545 hasConceptScore W4238208545C2778913445 @default.
- W4238208545 hasConceptScore W4238208545C2779881121 @default.
- W4238208545 hasConceptScore W4238208545C2780072125 @default.
- W4238208545 hasConceptScore W4238208545C2780306776 @default.
- W4238208545 hasConceptScore W4238208545C37501387 @default.
- W4238208545 hasConceptScore W4238208545C55493867 @default.
- W4238208545 hasConceptScore W4238208545C71924100 @default.
- W4238208545 hasConceptScore W4238208545C84393581 @default.
- W4238208545 hasIssue "1" @default.
- W4238208545 hasLocation W42382085451 @default.
- W4238208545 hasOpenAccess W4238208545 @default.
- W4238208545 hasPrimaryLocation W42382085451 @default.
- W4238208545 hasRelatedWork W1971830642 @default.
- W4238208545 hasRelatedWork W2045823137 @default.
- W4238208545 hasRelatedWork W2076036291 @default.
- W4238208545 hasRelatedWork W2099385407 @default.
- W4238208545 hasRelatedWork W2132485488 @default.
- W4238208545 hasRelatedWork W2151578115 @default.
- W4238208545 hasRelatedWork W2154511047 @default.
- W4238208545 hasRelatedWork W2155242563 @default.
- W4238208545 hasRelatedWork W2162750209 @default.
- W4238208545 hasRelatedWork W3177322528 @default.
- W4238208545 hasVolume "1" @default.
- W4238208545 isParatext "false" @default.
- W4238208545 isRetracted "false" @default.
- W4238208545 workType "article" @default.